PRC Training: Update on Synthetic Drugs 01.20.16

Post on 15-Apr-2017

474 views 0 download

Transcript of PRC Training: Update on Synthetic Drugs 01.20.16

Welcome to SACADA

Youth Prevention ProgramsProject Heart (8-13)Middle School (6th – 8th)Adolescent/Teen (14 – 18)Hype ProductionAlternative Programs

Adult and Family ServicesAssessment and ReferralsProject ADELANTEWORC Project

Resource CenterBrochuresDVD/CDPostersFact Sheets

Community CoalitionThe Circles of San Antonio

Education and TrainingDrugs & Alcohol TrendsWorkplaceCourt Mandated

The Region 8, Prevention Resource Center is one of 11 PRCs across Texas funded by the Texas

Department of State Health Services (DSHS). We cover 28 counties in South Central Texas.

PRC Purpose• Our purpose is to enhance and improve the

substance abuse prevention services throughout the State of Texas with our focus on the state’s three priorities of alcohol (underage drinking), Marijuana, Prescription drugs, Tobacco and other drugs.

The Purpose of the Regional Needs Assessment (RNA)

The regional needs assessment is a document developed with state, regional and local data to

provide the community at large with a comprehensive view of information about the

trends, outcomes and consequences associated with drugs and alcohol

ConsumptionAlcohol Marijuana Non-Medical Prescription Drug (NMDP) UseRegional Observations of Substance Tobacco

How to Use the Regional Needs Assessment (RNA)

To identify SA patterns and trends overtime.To identify gaps and strengths in data and

resources.To identify differences in SA across communities.To make DDD to support policy decisions and

grant writing activities.

Survey Time!!

Using Turning Point• Audience Response System• Choose your answer, only records answers once. • Poll closes after all votes are recorded.

Enter answ

er text.

..

Enter answ

er text.

..

Enter answ

er text.

..

Enter answ

er text.

..

25% 25%25%25%

Favorite Ice Cream Flavor

A. ChocolateB. VanillaC. StrawberryD. Rather eat cake

Have your ever attended a drug and alcohol abuse prevention training at your

work/school?

A. YesB. NoC. Don’t Know

Yes No

Don’t Know

0%0%0%

Would you like to attend a drug and alcohol abuse prevention training/event at

your work/school?

A. YesB. NoC. Don’t Know

Yes No

Don’t Know

0%0%0%

Do you know where you can get help/educated for alcohol or drug related

problems or concerns?

A. YesB. No C. Don’t Know

Yes No

Don’t Know

0%0%0%

Do you know how to recognize/explain signs of alcohol or drug use or abuse in a friend, family

member, co-worker or individual?

A. YesB. NoC. Don’t Know

Yes No

Don’t Know

0%0%0%

I am a: (choose all that apply)

A. StudentB. Work in the MH or

SA fieldC. VeteranD. None of the Above

Student

Work in

the M

H or SA field

Veteran

None of the Above

0% 0%0%0%

Will They Turn You into a Zombie?What Clinicians Need to Know about

Synthetic Drugs (2nd Edition)

Training Collaborators

• South Southwest Addiction Technology Transfer Center– University of Texas at Austin, School of Social

Work• Pacific Southwest Addiction Technology Transfer

Center– UCLA Integrated Substance Abuse Programs

• Centre for Addiction and Mental Health, Research Imaging Centre

18

Special Acknowledgements• Dr. Volker Auwaerter, University Medical Center

Freiburg, Germany• Dr. Michael Bauman, Intramural Research Program,

NIDA• Dr. Raimondo Bruno, University of Tasmania• Mathias Forrester, Texas Department of State Health

Services• Dr. Paul Griffiths, EMCDDA• James Hall, Nova Southeastern University• Dr. Barry Logan, National Medical Services Labs, Inc.• J. Randall Webber, JRW Behavioral Health Services

19

Special Acknowledgements• Dr. Volker Auwaerter, University Medical Center

Freiburg, Germany• Dr. Michael Bauman, Intramural Research Program,

NIDA• Dr. Raimondo Bruno, University of Tasmania• Mathias Forrester, Texas Department of State Health

Services• Dr. Paul Griffiths, EMCDDA• James Hall, Nova Southeastern University• Dr. Barry Logan, National Medical Services Labs, Inc.• J. Randall Webber, JRW Behavioral Health Services

20

What knowledge do you have on synthetic drugs?

A. No knowledgeB. Some knowledgeC. KnowledgeableD. Very knowledgeable

No knowledge

Some knowledge

Knowledgeable

Very knowledgeable

0% 0%0%0%

How comfortable are you speaking to someone about synthetic drugs?

A. UncomfortableB. ComfortableC. Very ComfortableD. Not sure

Uncomforta

ble

Comfortable

Very Comfortable

Not sure

0% 0%0%0%

Remember when this happened?

“Tales of Bath Salts and Zombie Cannibalism”

• Bath Salts made headlines in summer 2012 when a story of possible cannibalism was reported in Miami, FL

• The Miami-Dade Medical Examiner found no traces of bath salts, LSD, or synthetic marijuana in the perpetrator's system

• The sole psychoactive substance detected was cannabis (marijuana)

24

Have your heard these other media reports about “Bath Salts”?

• The man who slashed himself to remove the “wires” in his body.

• The mother who left her demon-ridden 2-year-old in the middle of the highway.

• The 21-year-old son of a family physician who, after snorting bath salts once, shot himself following 3 days of acute paranoia and psychosis, including hallucinations of police squad cars and helicopters lined up outside his house to take him away.

25SOURCE: Slomski, A. (2012). JAMA.

Educational Objectives At the end of this presentation, participants will be able to:

1. Identify the key characteristics and effects of synthetic drugs, most notably synthetic cannabinoids and synthetic cathinones.

2. Explain the neurobiology of synthetic drug use, and the differential impact of synthetic drugs vs. “classic” illicit drugs, such as marijuana and cocaine.

3. Describe the current information available on the availability and patterns of synthetic drug use at the statewide, regional and national level.

26

AN INTRODUCTION TO KEY TERMS AND DEFINITIONS

27

How Psychoactive Substances Work• Because of their chemical

structure, alcohol and drugs have dramatic effects on neurotransmitters in CNS

• Effects on:– Mental processes– Behavior– Perception– Alertness

SOURCE: NIDA. (2010). Drugs, Brains, and Behavior: The Science of Addiction. 28

Commonly Used Psychoactive Substances

SOURCE: National Institute on Drug Abuse.

SUBSTANCE EFFECTSAlcohol

(liquor, beer, wine)euphoria, stimulation, relaxation,

lower inhibitions, drowsiness

Cannabinoids (marijuana, hashish)

euphoria, relaxations, slowed reaction time, distorted perception

Opioids (heroin, opium, many pain meds)

euphoria, drowsiness, sedation

Stimulants (cocaine, methamphetamine)

exhilaration, energy

Club Drugs (MDMA/Ecstasy, GHB)

hallucinations, tactile sensitivity, lowered inhibition

Dissociative Drugs (Ketamine, PCP, DXM)

feel separated from body, delirium, impaired motor function

Hallucinogens(LSD, mushrooms, Mescaline)

hallucinations, altered perception

29

“Designer” Psychoactive Substances

SOURCE: http://www.drugs-forum.com, updated 2013. 30

“Designer” Psychoactive Substances

SOURCE: http://www.drugs-forum.com, updated 2013.

“Designer” Psychoactive Substances

SOURCE: http://www.drugs-forum.com, updated 2013.

“Designer” Psychoactive Substances

SOURCE: http://www.drugs-forum.com, updated 2013.

“Designer” Psychoactive Substances

SOURCE: http://www.drugs-forum.com, updated 2013.

Why People Use Psychoactive SubstancesWhy Start?

• Experimentation• Peer Pressure• Medical

Why Continue? • Relieve

stress/pain• Function better• Have fun/relax• Cope with mental

health disordersSOURCE: NIDA. (2010). Drugs, Brains, and Behavior: The Science of Addiction. 35

After repeated drug use, “deciding” to use drugs is no longer voluntary because

DRUGS CHANGE THE BRAIN!

SOURCE: NIDA. (2010). Drugs, Brains, and Behavior: The Science of Addiction. 36

A REVIEW OF SYNTHETIC DRUGS

37

“Designer” Psychoactive SubstancesTwo classes:

1. Stimulants: mephedrone, MPDV, piperazines, “bath salts”

2. Psychedelics: 2C-B, mescaline, DMT, etc.

Differences in users:3. Stimulant users similar to other ecstasy users;

(shifting to mephedrone and MPDV due to shortage of Ecstasy?)

4. Psychedelic users started ecstasy use earlier; were more frequent users; used multiple substances; had more legal, mental health, and social problems.

SOURCE: Bruno et al. (2012). Drug and Alcohol Dependence, 124(1-2), 19-25. 38

Examples of Major Synthetic PsychedelicsDRUG NAME DESCRIPTION

2C-I Phenethylamine, via PiHKAL; stimulant and hallucinogenSlow onset (1 hr); long duration of action (8-10 hr.)

2C-B Phenethylamine, via PiHKAL; visualsFaster onset; shorter duration than 2C-I

5-MeO-DMT Tryptamine; naturally occurring (toad, shamantic brews)Smoked: almost immediate, very intense, short effect (<30 min)

DMT Tryptamine; naturally occurringSmoked: almost immediate, very intense, short effect (<20 min)

SOURCE: Slide courtesy of R. Bruno et al., 2011, with revisions by James Hall, 2012. 39

Examples of Major Synthetic StimulantsDRUG NAME DESCRIPTIONMephedrone 4-methyl-methcathinone; “Miaow”

Similar to cocaine and MDMA (ecstasy)Methylone β-MDMA: 3,4-methylenedioxy-

methcathinone; “Explosion”Similar to cocaine and MDMA (ecstasy)

MDPV 3,4-methylenedioxyprovalerone; MDPV; “NRG-1” (Brandt, 2010); “Ivory Wave”Stimulant with rapid onset; 2-4 hour duration of action

BZP 1-benzyl-piperazoneSimilar to amphetamine1/10 potency of d-methamphetamine

SOURCE: Slide courtesy of R. Bruno et al., 2011, with revisions by James Hall, 2012. 40

From the term “Bath Salts” to…

Synthetic Cathinones

Mephedrone, methylone, 4-MEC

Stimulants related to methcathinone, MDMA, amphetamines

2C- Phenethylamines

Psychedelics related to mescaline

Some were created in the past to imitate MDMA

Tryptamines

5-MeO-DMT & 4-AcO-DMT

Psychedelics related to psilocin & bufotenin

Piperazines

BZP & TFMPP

Stimulants

And Dissociatives related to ketamine and PCP and Opioids related to morphine, fentanyl, and heroin.

Synthetic Drugs

• Not really “Spice,” “Bath Salts,” “Incense,” or “Plant Food”

• Chemically-based; not plant derived• Complex chemistry• Constantly changing to “stay legal”• Need to prove “intended to use” to convict

in some areas42

Which one is NOT a synthetic drug?

A. SpaceB. ClimaxC. CalgonD. Ivory Wave

SpaceClim

ax

Calgon

Ivory Wave

0% 0%0%0%

Spice/K2 is legal in Texas.

A. TrueB. False

TrueFa

lse

0%0%

The Texas Tribune: Cracking Down on K2

Synthetic CannabinoidsSpice vs. “Spice”

46

Synthetic CathinonesBath Salts vs. “Bath Salts”

47

Synthetic Cannabinoids• Wide variety of herbal mixtures• Marketed as “safe” alternatives to marijuana• Brand names include: “Spice,” “K2,” fake weed,

“Yucatan Fire,” “Skunk,” “Moon Rocks,” herbal incense, “Crazy Clown,” “Herbal Madness”

• Labeled “not for human consumption”• Contain dried, shredded plant material

(inert) and chemical additives that are responsible for their psychoactive effects.

SOURCE: NIDA. (2012). NIDA DrugFacts: Spice (Synthetic Marijuana). 48

Synthetic Cannabinoids• Mainly abused by smoking (alone or with

marijuana); may also be prepared as an herbal infusion for drinking.

• Many of the active chemicals most frequently found in synthetic cannabis products have been classified by the DEA as Schedule I controlled substances, making them illegal to buy, sell, or possess.

• Multiple “generations” of drugs.

SOURCE: NIDA. (2012). NIDA DrugFacts: Spice (Synthetic Marijuana). 49

Fox 29 Report: Del Rio Police Make K2 Bust After Students Overdose

JWH-018/073 arrived early and have come and gone. JWH-250 arrived a little later and has also cycled out. JWH-081 was part of a second wave that has already completed its

cycle. JWH-122 was part of the same wave but has persisted in popularity

and is part of the current scene. AM-2201 was part of the same second wave and has gained in

popularity, probably currently the most prevalent. JWH-022 and JWH-210 are showing signs of increasing popularity. Recent emergent drugs are the adamantoyl (AM-1248) and

tetramethylcyclopropyl (XLR-11 and UR-144) indoles which are ahead of the latest attempts to schedule these drug classes.

SOURCE: Logan, B.K. (2012). Testing Strategies to Monitor Novel/Emerging/Designer Drug Use in At-Risk Populations, Presented at 74th Annual CPDD.

The Emergence of Synthetic Cannabinoids

51

Why Spice became So Popular…• They induce psychoactive effects• They are readily available in retail stores

and online • The packaging is highly attractive• They are perceived as safe drugs• They are not easily detectable in urine and

blood samples

SOURCE: Fattore & Fratta. (2011). Frontiers in Behavioral Neuroscience, 5(60), 1-12. 52

Marijuana homolog exposures reported to the Texas Poison Center Network during 1/1/10-2/28/15 (n=2,946)

612

15

2932

41

6059596263

66

27

40

5864

60

46

90

67

43

27

39

27

44

36

61

48

67

39

47

32312526

18

29

37

4653

62

44

3340

24

40

29273230

4344

70

105

70

80

90

82

72

646866

0

20

40

60

80

100

120

Jan-10

Mar-10

May-10

Jul-1

0

Sep-10

Nov-10

Jan-11

Mar-11

May-11

Jul-1

1

Sep-11

Nov-11

Jan-12

Mar-12

May-12

Jul-1

2

Sep-12

Nov-12

Jan-13

Mar-13

May-13

Jul-1

3

Sep-13

Nov-13

Jan-14

Mar-14

May-14

Jul-1

4

Sep-14

Nov-14

Jan-15

Month

Num

ber

Texas ban 9/1/11 US ban 7/9/12

Source: South Texas Poison Control Network

Marijuana homolog exposures reported to the Texas Poison Center Network during 1/1/10-2/28/15 (n=2,946)

13221555

690

200400600800

10001200140016001800

<20 20+ Unknown

Patient age (years)

Num

ber

Age range: 1-75 years

Marijuana homolog exposures reported to the Texas Poison Center Network during 1/1/10-2/28/15 (n=2,946)

2271

658

170

500

1000

1500

2000

2500

Male Female Unknown

Patient gender

Num

ber

Marijuana homolog exposures reported to the Texas Poison Center Network during 1/1/10-2/28/15 (n=2,946)

2101

444273

1 3 1 1 1 10

500

1000

1500

2000

2500

Inhalation Ingestion Inhalation+Ingestion

Parenteral Inhalation+Parenteral

Dermal Ingestion+Dermal

Inhalation+Ingestion+Parenteral

Unknown

Route

Num

ber

Marijuana homolog exposures reported to the Texas Poison Center Network during 1/1/10-

2/28/15 (n=2,946)

2505

146 107 26 1620

500

1000

1500

2000

2500

3000

Abuse/misuse Attemptedsuicide

Unintentional Adverse reaction Unknown

Exposure reason

Num

ber

Marijuana homolog exposures reported to the Texas Poison Center Network during 1/1/10-2/28/15 (n=2,946)

2040

75 5 10 62 1 119 36

598

0

500

1000

1500

2000

2500

Ownresidence

Otherresidence

Workplace Healthcarefacility

School Foodservice

Public area Other Unknown

Exposure site

Num

ber

Marijuana homolog exposures reported to the Texas Poison Center Network during 1/1/10-2/28/15 (n=2,946)

431

25 6

2141

8 2305

280

500

1000

1500

2000

2500

Ownresidence

Otherresidence

Workplace Healthcarefacility

School Publicarea

Other Unknown

Caller site

Num

ber

Marijuana homolog exposures reported to the Texas Poison Center Network during 1/1/10-2/28/15 (n=2,946)

166

2335

407

33 50

500

1000

1500

2000

2500

On site (home) Already athealthcare facility

Referred tohealthcare facility

Other Unknown

Management site

Num

ber

Marijuana homolog exposures reported to the Texas Poison Center Network during 1/1/10-2/28/15 (n=2,946)

162

645

1202

232

4 1

178

489

32 10

200

400

600

800

1000

1200

1400

No effect Minor Moderate Major Death NF(nontoxic)

NF (minor?) NF (toxic?) Unrelated Unknown

Medical outcome

Num

ber

NF: not followed

Marijuana homolog exposures reported to the Texas Poison Center Network during 1/1/10-2/28/15 (n=2,946), caller county

Anderson – 13Andrews – 3Angelina – 6Aransas – 3Atascosa – 2Bailey – 1Bastrop – 1Bee – 4Bell – 46Bexar – 218Bosque – 1

Bowie – 6Brazoria – 28Brazos – 9Brewster – 1Brown – 8Burleson – 1Burnet – 3Caldwell – 2Calhoun – 4Cameron – 17Camp – 2

Marijuana homolog exposures reported to the Texas Poison Center Networkduring January 1, 2010-February 28, 2015, by caller county

No. calls

5-9

4

3

2

1

10+

Marijuana homolog exposures reported to the Texas Poison Center Network during 1/1/10-2/28/15 (n=2,946), clinical effects

• Cardiovascular– Asystole – 4– Bradycardia – 77– Cardiac arrest - 6 – Chest pain – 142– Conduction disturbance

– 28– Dysrhythmia – 13– ECG change – 21– Hypertension – 275

– Hypotension – 111– Tachycardia – 993

Six States Report Cases of Kidney Damage Linked to Synthetic Cannabinoids

• Sixteen cases of kidney damage reported by CDC– All admitted to hospital– Five required hemodialysis

• Fifteen of the patients were male; ranged in age from 15 to 33, no history of kidney disease

• In early Feb 2013, UA-Birmingham reported 4 cases of previously healthy young men, whose acute kidney injury was associated with synthetic marijuana– Symptoms of nausea, vomiting, and abdominal pain – All four men recovered kidney function, and none

required dialysisSOURCE: Join Together Online. (2013). Story published February 15, 2013. 65

Synthetic Cannabinoid Use Leads to Dangerous Symptoms in Pregnant Women

• Leads to symptoms similar to those caused by dangerous conditions known as preeclampsia and eclampsia– Preeclampsia is marked by high blood pressure

and a high level of protein in the urine – Preeclampsia can lead to eclampsia, which can

cause a pregnant woman to develop seizures or coma, and in rare cases is fatal

SOURCE: Join Together Online, May 8, 2013. 66

Synthetic Cathinones

• Could be MDPV, 4-MMC, mephedrone, or methylone

• Sold on-line with little info on ingredients, dosage, etc.

• Advertised as legal highs, legal meth, cocaine, or ecstasy• Taken orally or by inhaling• Serious side effects include tachycardia, hypertension,

confusion or psychosis, nausea, convulsions• Labeled “not for human consumption” to get around

laws prohibiting sales or possession

SOURCE: Wood & Dargan. (2012). Therapeutic Drug Monitoring, 34, 363-367. 67

Navy Bath Salts PSA

Synthetic Cathinones are b-keto (‘bk’) Analogs of Amphetamine

N CH3

HO

CH3

Methcathinone

N CH3

HO

CH3

4-Methylmethcathinone(Mephedrone)

H3C

N CH3

H

CH3

Methamphetamine

NO

O

O

3,4-Methylenedioxypyrovalerone(MDPV)

NO

CH3

O

O

3,4-Methylenedioxmethcathinone(Methylone)

CH3

H

69

Sources and Continuing Availability• A number of synthetic marijuana and bath salt

products appear to originate overseas and are manufactured in the absence of quality controls and devoid of governmental regulatory oversight.

• The large profits from sales, plus the fact that these chemicals can be easily synthesized to stay one step ahead of control, indicate there is no incentive to discontinue retail distribution of synthetic cannabinoid products under the current statutory and regulatory scheme.

SOURCES: ONDCP, 2012; EMCDDA, 2011. 70

Human Exposure Calls to U.S. Poison Centers on Synthetic Cannabinoids and Cathinones and

the Effect of Federal Regulations

71SOURCE: American Association of Poison Control Centers, 2010-2013 data.

2010 2011 2012 20130

100

200

300

400

500

600

700

800

The Effect of Federal Controls on Syn-thetic Cannabis Calls to Poison Centers

2010 2011 2012 20130

100

200

300

400

500

600

700

800

The Effect of Federal Controls on Synthetic Cathinone Calls to Poison

Centers

THE EFFECTS OF SYNTHETIC DRUGS

72

Short-Term Effects of Synthetic Cannabinoids

• Loss of control• Lack of pain response• Increased agitation• Pale skin• Seizures• Vomiting• Profuse sweating

• Uncontrolled spastic body movements

• Elevated blood pressure• Elevated heart rate• Heart palpitations

In addition to physical signs of use, users may experience severe paranoia, delusions, and hallucinations.

SOURCE: Join Together Online, December 4, 2012. 73

Cannabis vs. Synthetic Cannabinoids: Effects Seen in Clinical Cases

• Most symptoms are similar to cannabis intoxication:– Tachycardia– Reddened eyes– Anxiousness– Mild sedation– Hallucinations– Acute psychosis– Memory deficits

• Symptoms not typically seen after cannabis intoxication:– Seizures– Hypokalemia– Hypertension– Nausea/vomiting– Agitation– Violent behavior– Coma

SOURCES: Hermanns-Clausen et al. (In Press), Addiction; Rosenbaum et al. (2012). Journal of Medical Toxicology; Forrester et al. (2011). Journal of Addictive Disease; Schneir et al. (2011). Journal of Emergency Medicine. 74

Synthetic Cannabinoids:Other Considerations

• Unlike cannabis, synthetic cannabinoids have no therapeutic effects• Example: no cannabidiol (anti-anxiety), so mood effects

unpredictable• Packets can contain other psychoactive substances:

opioids, oleamide, harmine/harmaline (MAO-Is) that can interact with the synthetic cannabinoid

• Cancer-causing potential of inhaling smoke from these compounds unknown

SOURCE: Doris Payer, #CHSF2013. 75

Agitation 82%Combative/Violent behavior 57%Tachycardia 56%Hallucinations 40%Paranoia 36%Confusion 34%Myoclonus/Movement disorders 19%Hypertension 17%Chest pain 17%CPK elevations 9%

Clinical Symptoms of Synthetic Cathinone Use in Patients Admitted to the Emergency Department (N=236)

SOURCE: Spiller et al. (2011). Clinical Toxicology, 49, 499-505. 76

THE EPIDEMIOLOGY OF SYNTHETIC DRUG USE

77

Emerging Drug Items Identified in U.S. NFLIS Forensic Labs: 2010-2012

Synthetic Cannabinoids Synthetic Cathinones -

5,000

10,000

15,000

20,000

25,000

30,000

35,000

40,000

45,000

3,286 731

23,688

6,949

41,458

14,239

201020112012

SOURCE: U.S. DEA, Office of Diversion Control, NFLIS data, 2012. 78

Number of Unique Types of Synthetic Drugs Identified Nationally: NFLIS (2010-2012)

Synthetic Cannabinoids Synthetic Cathinones0

10

20

30

40

50

60

19 17

44

25

55

37

201020112012

SOURCE: U.S. DEA, Office of Diversion Control, NFLIS data, 2012. 79

Calls Received by U.S. Poison Control Centers for Human Exposure to Synthetic

Marijuana, 2010 to July 2013

2010 2011 2012 1/2 20130

1,0002,0003,0004,0005,0006,0007,0008,000

2,906

6,968

5,205

1,413

There was 1 cannabinoiddeath in 2010 and 4 in 2011

80SOURCE: American Association of Poison Control Centers, updated August 30, 2013.

Past Year Drug Use by 12th Grade Students: MTF, 2012

Marijuana

Synthetic Cannabis

Synthetic Cathinones

MDMA

Hallucinogens

LSD

0% 5% 10% 15% 20% 25% 30% 35% 40%

36.0%

11.3%

1.3%

3.8%

5.0%

2.1%

SOURCE: Monitoring the Future Survey, 2012 results. 81

Percentage of U.S. Students (Grades 9 to 12) Reporting Past Year Alcohol and Other Drug Use, 2012 (N=3,884)

Bath SaltsSalvia

MethamphetamineCrack

OTC Cough MedicineInhalants

CocaineEcstasy

Rx StimulantsRx Pain Relievers

Synthetic MarijuanaMarijuana

Alcohol

0 10 20 30 40 50 603%4%4%4%

7%7%7%8%9%10%

12%39%

57%

82SOURCE: Adapted by CESAR from The Partnership for a Drug-Free America and the MetLife Foundation, The Partnership

Attitude Tracking Study (PATS): Teens and Parents, 2013.

Emergency Room Visits Related to Synthetic Cannabis and

Cathinones: DAWN, 2011

% Male % Under Age 21

% Sent to ICU or Sub.

AbuseTreatment

% Discharged

Home

Synthetic Cannabis 70% 55% 3% 78%

Synthetic Cathinones 76% 14% 12% 55%

83SOURCE: OAS, SAMHSA-CSAT. (2013). Drug Abuse Warning Network, 2011 data.

Synthetic Cannabinoids Identified in U. S. NFLIS Forensic Labs

JWH-018 64%JWH-073 ; 303;

9%

JWH-081 ; 182

JWH-250 ; 461; 14%

19 variations reported in 2010

n=3,286

AM-2201 35%

JWH-01816%

JWH-081 6%

JWH-12213%

JWH-210 9%

SYNTHETIC CANN7%

44 variations reported in 2011

n=23,688

AM-220141%

JWH-122 6%

MAM-2201 4%

SYNTHETIC CANN

6%

UR-144 13%

XLR-1114%

55 variations reported in 2012

n=41,458

84SOURCE: U.S. DEA, Office of Diversion Control, NFLIS data, 2010-2012.

Calls Received by U.S. Poison Control Centers for Human Exposure to Synthetic Cathinones,

2010 to July 2013

2010 2011 2012 Jan-June 2013

0

1,000

2,000

3,000

4,000

5,000

6,000

7,000

304

6,136

2,656

528

SOURCE: American Association of Poison Control Centers, updated August 30, 2013.

There were no synthetic cathinone fatalities in 2010 but there were 18 in 2011

85

Synthetic Cathinones Identified in U.S. NFLIS Forensic Labs

17 varieties identified

in 2010n=731

34 varieties identified

in 2011n=6,949

48 varieties identified

in 2012n=14,239

4MMC

33%

MDPV

52%

METHYLONE11%

4-MEC4%

4-MMC5%

MDPV53%

METHYLONE26%

ALPHA-PBP18%

PENTEDRONE5%

4-MMC20%

MDPV21%

METHYLONE 23%

86SOURCE: U.S. DEA, Office of Diversion Control, NFLIS data, 2010-2012.

19 DU 0 0

0

22 DU

95 DU10 LO68 DU

11 LO, 1930 DU

109 DU

1 DU0

675 DU

656 DU12 DU

4 LO4 DU0

0

603 DU

1 DU 45 DU

6 DU

2 LO24 DU

0

5 DU

02 DU

596 LO71 DU

Synthetic Drugs for Region 8

Uniform Crime Reporting 2014

Counties that had an Increase in Seizures by Dose Units in 2014

Atascosa

BanderaBexa

r

CalhounDewitt

Dimmit

Frio

Guadalupe

Jackson

Kerr

Medina

Uvalde

Val Verde

0

500

1000

1500

2000

2500

Dose Units

2013 2014

Counties that had a Decrease in Seizures by Dose Units in 2014

Comal Goliad Kendall Lavaca Maverick Victoria Wilson0

500

1000

1500

2000

2500

Dose Units

2013 2014

State and Regional Comparisons of Seizures by Dose Units in 2014

Region 8 Texas0

50000

100000

150000

200000

250000

Dose Units

2013 2014

0.23%2.73 %

Psychedelic Drug Use and Baby Boomers• 32 million Americans have used any psychedelic drug at

least once in their lifetimes— about 17% of all American adults between the ages of 21-64.

• Overall rates of lifetime psychedelic use are roughly the same among the 'baby boomers' and younger adults

• Lifetime psychedelic drug use among baby boomers aged 50 to 64 was on par with that of younger adults aged 21-25, about 15%.

• The highest rate was among adults aged 30-34 (over 20%) • Adults over the age of 65 largely missed the advent of

psychedelic drugs in popular culture, since only 1% reported using them.

SOURCE: http://www.medicaldaily.com/psychedelic-drug-use-united-states-common-now-1960s-generation-245218#.Ugzg8FaFeGA.email. 91

OTHER NOTABLE SYNTHETIC DRUGS – “NEW AND OLD”

92

MDMA (Ecstasy)• 3, 4-methylenedioxy-methamphetamine• Street terms: Adam, E, X, XTC, love drug, Molly • A synthetic, psychoactive drug with both

stimulant and hallucinogenic properties similar to methamphetamine and mescaline

• Adverse effects: enhanced physical activity, sweating, lack of coordination, mental confusion, jaw clenching, hyperthermia, and agitation

NIDA. (2010). NIDA InfoFacts: MDMA (Ecstasy). 93

Glimpses of MDMA Situation in U.S.: 1999-2013

20012002

20032004

20052006

20072008

20092010

20112012

20130

102030405060708090

Results of Pill Tests Containing MDMA*

Any MDMA MDMA Only

2006 2007 2008 2009 2010 2011 20120

5000

10000

15000

20000

25000

30000

MDMA Reports: NFLIS Forensic Labs 2006-2012

SOURCES: http://www.ecstasydata.org/stats_substance_by_year.php; U.S. DEA, Office of Diversion Control, NFLIS data, 2006-2012. 94

What is “Molly”?1. Ecstasy pills with little MDMA and lots of caffeine, meth,

assorted drugs? OR2. A pure crystalline form of MDMA, most often sold as a powder

filled capsule? OR3. Methylone? Bath salts?

• Reports of desired effects of euphoria, but also increased paranoia, agitated delirium, scary hallucinations, psychotic episodes, violent or destructive self-harm behavior, including death

• Bottom line - Molly usually is not a pure form of MDMA, but may be a drug that can be very dangerous since its contents are unknown

SOURCE: Join Together Online. (2013). Story published June 24, 2013. 95

Someone Help Me Find “Molly”

Krokodil• Russian cheap replacement drug for heroin made from

cooking down desomorphine with gasoline, paint thinner, alcohol, iodine, red phosphorous (match heads), etc.

• In Russia, lack of clean needles and methadone, high cost of heroin, poverty, high numbers of HIV+ individuals, etc.

• No confirmed cases of desomorphine in the U.S. since 2 were identified in 2004.

• Injuries that look like krokodil can be due to shared dirty needles, bacteria, toxic adulterants, gangrene, staph infection, MRSA.

97

What do you do if someone has taken a Synthetic Drug?

• Call your local poison center at 1-800-222-1222– 57 poison centers around the country have experts

waiting to answer your call. – The experts at the Center can help you decide

whether someone can be treated at home, or whether he or she must go to a hospital.

• Dial 9-1-1 immediately if they:– Stop breathing– Collapse– Have a seizure

SOURCE: American Association of Poison Control Centers (AAPCC). (2012). Facts about Bath Salts.

…or if they have taken one of these and are having physical symptoms or behaving in a way that is concerning to you

99

In Summary: Key Points

• Research is needed to better understand the side effects and long-term consequences associated with the use of synthetic cannabinoids and synthetic cathinones.

• More toxicological identification of these new drugs, more information on the sources of them, as well as their distribution and patterns of use is needed to curtail future increases in use.

100

• We do not have human neurobiological data or long-term data, but we can extrapolate a few key points from the existing literature:– Synthetics vs. Classics: Neurobiological concerns

hold up, plus more– In all cases, neurobiology predicts abuse potential– In general, synthetic versions are not a simple

substitute for “classics” – effects tend to be more intense (including side effects), some unexpected, and some new interactions that were not a concern before

In Summary: Key Points

101SOURCE: Doris Payer, #CHSF2013.

Resources for Continued Learning

• American Association of Poison Control Centers, www.aapcc.org

• Drug Enforcement Administration, www.dea.usdoj.gov • European Monitoring Centre for Drugs and Drug

Addiction, www.emcdda.europa.eu • National Institute on Drug Abuse, www.nida.nih.gov• Office of National Drug Control Policy, www.ondcp.org • Pacific Southwest ATTC, www.psattc.org • Refer to the Synthetic Drugs Reference List**

102

For more information:Jane C. Maxwell: jcmaxwell@austin.utexas.eduBeth Rutkowski: brutkowski@mednet.ucla.eduDoris Payer: doris.payer@camh.ca

Pacific Southwest ATTC and South Southwest ATTC: http://www.psattc.orghttp://www.attcnetwork.org/regcenters/index_southsouthwest.aspt

103

Call to Action and Closing Message • Work with your community

coalitions.

• Keep yourself updated on the most recent data. Visit pro-drug websites too!

• Be cognizant and aware of potential data or data sources we could utilize for the RNA.

Questions from the Audience

Community Agreement with PRC 8 • Provide the PRC with any data that may

contribute the data repository (alcohol (underage drinking), marijuana, and prescription drugs).

• Assist the PRC with networking and coordination to help collect data and identify resources for the regional data collection.

• Assist PRC in promoting community efforts to raise awareness and generate support in attending PRC presentations on local, county regional data collected for RNA.

• Offer networking assistance to strengthen prevention efforts in our community.

We WANT You.. To Partner with us!

Recruitment for Advisory Group

Every 3rd Tuesday of the

month from 1:30pm –

2:30pm, before the COSA Coalition Meeitng.